Editor’s note: Recently, Cynthia Waldman of HCMBeat had the chance to interview Dr. Laura Robertson of Tenaya Therapeutics . Dr. Robertson is charged with leading the clinical development program for Tenaya’s experimental gene therapy treatment for HCM.
You have probably read about gene therapy and wondered whether it could ever be used to treat hypertrophic cardiomyopathy. HCMBeat has written several stories about the growing field of gene therapy, shining a light on the researchers and companies focused on this effort.
HCM Beat 